Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
185M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
3.03M
-
Shares change
-
+182K
-
Total reported value, excl. options
-
$30.9M
-
Value change
-
+$1.76M
-
Number of buys
-
15
-
Number of sells
-
-15
-
Price
-
$10.19
Significant Holders of HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) as of Q2 2021
37 filings reported holding AHAC - HUMACYTE, INC. - Common Stock, par value $0.0001 per share as of Q2 2021.
HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.03M shares
of 185M outstanding shares and own 1.64% of the company stock.
Largest 10 shareholders include Maven Securities LTD (500K shares), Tudor Investment Corp Et Al (403K shares), UBS OCONNOR LLC (300K shares), Altium Capital Management LP (275K shares), COWEN AND COMPANY, LLC (241K shares), Alpine Global Management, LLC (210K shares), Eversept Partners, LP (205K shares), P SCHOENFELD ASSET MANAGEMENT LP (200K shares), Omni Partners US LLC (192K shares), and TENOR CAPITAL MANAGEMENT Co., L.P. (100K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.